BrainsWay Says Secondary Analysis Of Deep TMS Trial Published In Journal Of Affective Disorders Showed Suicidal Ideation Fell From 22.5% Of 89 Patients At Baseline To 6.7% At Six Weeks

Loading news article.

BrainsWay Says Secondary Analysis Of Deep TMS Trial Published In Journal Of Affective Disorders Showed Suicidal Ideation Fell From 22.5% Of 89 Patients At Baseline To 6.7% At Six Weeks | WAPE

BrainsWay Says Secondary Analysis Of Deep TMS Trial Published In Journal Of Affective Disorders Showed Suicidal Ideation Fell From 22.5% Of 89 Patients At Baseline To 6.7% At Six Weeks

Article summary

Related companies

Comments —